PharmaShots Weekly Snapshots (Dec 14-18, 2020)
Sandoz to Launch Hyrimoz (biosimilar, adalimumab) in Canada
Published: Dec 17, 2020 | Tags: Authorization, Biosimilar, canada, health, Humira, Hyrimoz, Launch, receives, Sandoz
Amgen's Riabni (biosimilar, rituximab) Receives the US FDA's Approval for Multiple Diseases
Published: Dec 17, 2020 | Tags: Adult, Amgen, approval, Biosimilar, CLL, GPA, MPA, NHL, patients, receives, RIABNI, Rituxan, Rituximab, rituximab-arrx, Us FDA
NOWDiagnostics Receives CE Mark for its ADEXUSDx COVID-19 Antibody Fingerstick Test
Published: Dec 17, 2020 | Tags: ADEXUSDx COVID-19, Antibody Fingerstick Test, COVID-19, Launches, NOWDiagnostics
Published: Dec 17, 2020 | Tags: (belimumab), Active, Benlysta, GSK, Lupus Nephritis (LN), Recieves, US, US FDAs Approval
GSK Signs an Exclusive License Agreement with Surface Oncology to Develop and Commercialize SRF813
Published: Dec 17, 2020 | Tags: Commercialize, Develop, Exclusive License Agreement, GSK, Signs, SRF813, Surface Oncology
Moderna's mRNA-1273 Receives the US FDA's Advisory Committee Vote Supporting EUA Against COVID-19
Published: Dec 17, 2020 | Tags: Advisory, Against, Committee, COVID-19, EUA, Moderna, receives, Supporting, US, Us FDA, vaccine, Vote
Novartis to Acquire Cadent Therapeutics for ~$770M
Published: Dec 17, 2020 | Tags: $770M, Acquire, Cadent, Novartis, therapeutics
Published: Dec 16, 2020 | Tags: (KTE-X19), EC's Conditional Marketing Authorization, Europe, Kite, receives, Relapsed or Refractory Mantle Cell Lymphoma, Tecartus, ZUMA-2 Study
Published: Dec 16, 2020 | Tags: Advanced, Amgen, KRAS G12C, Metastatic, Mutation, NDA, NSCLC, reports, Sotorasib, Submission, Us FDA
Published: Dec 16, 2020 | Tags: approval, Health Canada, Novartis, One-Time Gene Therapy, receives, Spinal Muscular Atrophy (SMA), Zolgensma
Novo Nordisk to Initiate a P-lll Study of Semaglutide to Treat Alzheimer Disease
Published: Dec 16, 2020 | Tags: Alzheimer Disease, Novo Nordisk, P-lll Development, Semaglutide, Start
Published: Dec 15, 2020 | Tags: Advisory, Committee, Entresto, HFpEF, Novartis, patients, Positive, receives, Recommendation, Treat, USFDA
Abbott's COVID-19 IgG Quantitative Antibody Blood Test Receives CE Mark
Published: Dec 15, 2020 | Tags: Abbott, antibody, Blood, CE Mark, COVID-19, IgG, Quantitative, receives, Test
Ellume's COVID-19 Home Test Receives the US FDA's EUA as First Over-the-Counter Diagnostic Test
Published: Dec 15, 2020 | Tags: Antigen, COVID-19, Ellume, EUA, receives, Test, Us FDA
Published: Dec 15, 2020 | Tags: Belt, Bone Health Technologies, Breakthrough, Designation, Device, OsteoBoost, receives, USFDA, Vibration
Published: Dec 15, 2020 | Tags: (budesonide oral suspension), Eosinophilic Esophagitis (EoE), NDA, reports, TAK-721, Takeda, US FDA's Acceptance
Published: Dec 15, 2020 | Tags: (tirbanibulin), Actinic Keratosis, Athenexs, Face, Klisyri, receives, Scalp, US FDAs Approval
Published: Dec 15, 2020 | Tags: Agreement, Commercialization, Development, Filgotinib, Galapagos, Gilead, Jyseleca, Signs
Lilly to Acquire Prevail Therapeutics for ~$1.04B
Published: Dec 15, 2020 | Tags: ~$1.04B, Acquire, Lilly, Prevail Therapeutics
EMA's CHMP Recommends Four-Week Dosing Option for AstraZeneca's Imfinzi to Treat Unresectable NSCLC
Published: Dec 15, 2020 | Tags: approval, AstraZeneca, CHMP, EU, Imfinzi, NSCLC, Recommended, Unresectable
CureVac Commences P-llb/lll Trial of CVnCoV for COVID-19
Published: Dec 14, 2020 | Tags: Commences, COVID-19, CureVac, CVnCoV, P-llb/lll Trial
Roche Launches Cobas PIK3CA Mutation Test for Patients with Advanced or Metastatic Breast Cancer
Published: Dec 15, 2020 | Tags: Advanced, breast, Cancer, Cobas, Launch, Metastatic, Mutation, patients, PIK3CA, Roche, Test
Samsung Bioepis Initiates P-Ill Study of SB16 Proposed Biosimilar to Prolia (denosumab)
Published: Dec 14, 2020 | Tags: (Denosumab), Initiates, P-Ill Study, Prolia, Proposed Biosimilar, Samsung Bioepis, SB16
Published: Dec 14, 2020 | Tags: Agreement, Commercialization, Develop, Genentech, Relay Therapeutics, RLY-1971, Signs, Worldwide License
Published: Dec 14, 2020 | Tags: approval, Genentech, Multiple Sclerosis, ocrelizumab, Ocrevus, Primary, Progressive, receives, Relapsing, Us FDA
Published: Dec 11, 2020 | Tags: approval, AstraZeneca, breast, Cancer, CHMP, Daiichi Sankyo, Deruxtecan, EU, HER2, Metastatic, Positive, Recommended, trastuzumab
Novartis' Ruxolitinib Fails to Meet its Primary Endpoint in P-lll RUXCOVID Study for COVID-19
Published: Dec 14, 2020 | Tags: COVID-19, Novartis, P-lll, reports, results, RUXCOVID Study, ruxolitinib
AstraZeneca's Trixeo Aerosphere Receives EU's Approval for the Maintenance Treatment of COPD
Published: Dec 14, 2020 | Tags: AstraZenecas, China, EUs Approval, Japan, moderate to severe chronic obstructive pulmonary disease (COPD), receives, Trixeo Aerosphere, US
Alvotech and Fuji Pharma Extends Agreement for the Commercialization of Four Biosimilars in Japan
Published: Dec 10, 2020 | Tags: Agreement, Alvotech, Biosimilar, Commercialization, Extends, Four, Fuji Pharma, Japan, Medicines
Pfizer and BioNTech's BNT162b2 Receives the US FDA's EUA to Prevent COVID-19
Date: Dec 11, 2020 | Tags: BioNTech, BLA, BNT162b2, COVID-19, EUA, files, Pfizer, Prevent, receives, Us FDA
AstraZeneca to Acquire Alexion for $39B
Published: Dec 12, 2020 | Tags: $39B, Acquires, Alexion, AstraZeneca
Related News: PharmaShots Weekly Snapshots (Dec 7-11, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com